Stocks were mixed Monday, with the Dow Jones Industrial Average up 0.05%, the Nasdaq down 0.42% and the S&P 500 down 0.06%. Today’s winner was a company who will have a new CEO. One of today’s losers was a drug company with an unsuccessful drug trial, while another company lost an arbitration ruling as it sought damages.
These are Monday’s market winner and losers.
Biggest Winner
Shares of Jaguar Mining Inc. (NYSE: JAG) are up 10.39% to $1.26 on trading volume of 1.7 million shares. The mining company on Monday announced the appointment of David Petroff as chief executive officer. The 52-week high is $8.18.
Biggest Losers
Shares of Geron Corporation (NASDAQ: GERN) are down 54.48% to $1.32 on trading volume of 9.8 million shares. The company announced it would halt the study of its breast cancer drug after it found it didn’t improve the condition of patients. The 52-week low is $1.25.
Shares of Nordion Inc. (NYSE: NDZ) are down 37.75% to $6.63 on trading volume of 2.9 million shares. The medical isotopes company announced it was suspending its dividend after an arbitration panel dismissed its claim to receive damages from Canadian-state-owned Atomic Energy of Canada Limited. Before Monday, the 52-week low was $8.00
Smart Investors Are Quietly Loading Up on These “Dividend Legends”
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats.
There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside.
If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
By providing your email address, you agree to receive communications from us regarding website updates and other offerings that may be of interest to you.
You have the option to opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms of Use.
